Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide vs olanzapine-based antiemetic regimens for delayed CINV
ChiCTR2100045323Phase 4Recruiting
- Sponsor
- Hainan General Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing Thalidomide regimen arm with Olanzapine regimen arm (2 arms). Primary endpoint: Complete response of delayed vomiting. Started Apr 2021; status: recruiting.
02
Drugs
thalidomideolanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2100045323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045323.